The second embryo blunder in a matter of months by Monash IVF has seen its share price further plunge, now down 60% since August. Meanwhile, the market as a whole is almost at a record high thanks to the banks. In the United States, investors' risk appetite is sky-high even as Chinese exports to the US slump.
